RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Loading upYou are missing some points in all your good ones.
They have licensing income currently, about $300,00.00 a month ( as reported here many times from different posters)
Their current cost run-rate is $350,000.00 per month. So the cost impact to cash flow very low right now.
When production starts their margins will be higher ( Agreed they need to get going on this)
due to higher efficiencies and having their base costs low.
Their timeline is not that far behind. About a quarter. But given the WEED/CBD meltdown industry-wide and the current CBD-19 scenario they are actually sticking to their plan better than most would have thought.
Notwithstanding waiting on the usual licensing and machinery delays, not in their control, it is why OILS is still 10-15% of the share price of the big three (Labs,Vlns,Nept) and has not lost a step in 12 months.
Who would have thought 12 months ago that OILS would trade for more than TGOD or that TRST, ASNT, and others would be bankrupt?
I still see another wave of Patents on the way which does differentiate OILS from the pack. The world has just been a little busy to do business as normal. Maybe the TSX and the DOW could be indicating there is strength financially that we are not giving credit for? Maybe!
JMHO